CClinicalTrials.gg
TerminatedNCT02362282CogGaitUpdated Feb 11, 2019Results posted

Combined Cognitive and Gait Training

An interventional study of Gait training and cognitive training in Stroke, sponsored by VA Office of Research and Development. Terminated at 1 site in United States. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-02-11.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

Why this study was terminated
unable to hire qualified personnel to run the study
Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Study summary

Recent research in gait training for stroke survivors showed that coordinated gait components can be best restored using the following interventions together: coordination exercises, over ground gait training, and body weight supported treadmill training (BWSTT). These results are important because, to the investigators' knowledge, there have been no other reports of the restoration of coordinated gait components for those with persistent gait deficits (> 6 months after stroke). However, a remaining problem was that the restored coordinated gait movements measured in the laboratory did not generalize for many subjects to the everyday environment. The confluence of several factors can cause lack of generalization. First, dual task performance (gait and cognitive attention task) can degrade both gait and attention ability, even in healthy adults. Second, stroke can impair attention. Third, during walking in the everyday environment, attention is required in order to safely process normally occurring stimuli. Therefore, given the success of the new gait training protocol in the lab setting, it is important to address the problems remaining for generalization of the recovered coordinated gait pattern to the everyday environment. The primary hypothesis of this study is that greater gains in gait speed will be produced by combined motor and cognitive training versus motor training alone.

Read the detailed description

Aim 1, Hypothesis Ia: Comparison of combined motor and cognitive training vs motor training alone. For Aim 1, Hypothesis Ia, this will be a randomized, controlled study. For the two groups, 38 subjects will be enrolled and randomized to either: A) Motor + Cognitive Training; or B) Motor Training alone. Subjects will first be stratified according to coordination and gait deficit severity, as described below. After stratification, the subject will be randomized to one of the two intervention groups for Hypothesis Ia. All the subjects will receive treatment 5 times/week, 3hrs/session, for 12 weeks or for a total of 60 treatment sessions. Group A will receive combined motor and cognitive training; Table 2 (below) shows the graduated approach to providing combined gait and cognitive training. Data collection will be at weeks 1, 6, 12, and 24 (i.e., before, mid-treatment and after treatment, and then 3 months after the end of the treatment protocol. Comparison will be made between the two groups to determine whether there was any additive effectiveness of the cognitive training.

Aim 2, Hypotheses IIa-d: Pre/post-treatment comparisons within Group A, receiving combined motor and cognitive training. For Aim 2, Hypotheses IIa-d, this will be a single cohort pre/post-treatment comparison within Group A receiving combined motor and cognitive training.

Aim 3, Hypotheses IIIa-d: Pre/post-treatment comparisons within Group B, receiving motor training alone. For Aim 3, Hypotheses IIIa-d, this will be a single cohort pre/post-treatment comparison within Group B, receiving motor training alone.

02

Conditions studied

  • Stroke

Keywords

  • stroke
  • walking
  • cognition
  • rehabilitation
03

In context

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

Stroke Survivor inclusion/exclusion criteria Inclusion Criteria

  • Cognition sufficiently intact to give valid informed consent to participate. *
  • Sufficient endurance to participate in rehabilitation sessions.
  • Ability to follow 2 stage commands.
  • Medically Stable
  • Age > 21 years.
  • Impaired ambulation as follows: inability to flex the knee and ankle in the sagittal plane, in a normal manner so the foot clears the floor; inability to control normal knee angle during single limb weight bearing during stance phase.
  • At least 6 months post stroke.

Able-bodied Inclusion criteria

  • Criteria to be included is that they should be healthy with no history of a neurological disease or orthopedic impairment.**
  • Not Pregnant.
  • No Claustrophobia (only for the sub-sample asked to undergo fMRI.)
  • No counterindications to MR scanning including, pregnancy, weight inappropriate for height, ferrous objects within the body (only for the sub-sample asked to undergo fMRI.)

Exclusion Criteria:

Exclusion Criteria

  • Acute or progressive cardiac, vascular, renal, respiratory, neurological disorders or malignancy.
  • Active psychiatric diagnosis or psychological condition, or active drug/alcohol abuse.
  • Lower motor neuron damage or radiculopathy.
  • Orthopedic impairment. **
  • More than one stroke.
  • Cerebellar dysfunction.
  • Fugl-Meyer lower limb motor sub-score greater than 32.
  • No simultaneous gait rehabilitation participation.
  • Pregnant.
  • Claustrophobia (only for the sub-sample asked to undergo fMRI.)
  • Criteria specific to MR scanning, including pregnancy, weight inappropriate for height, ferrous objects within the body (only for the sub-sample asked to undergo fMRI.)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
12 participants (actual)

Study arms

  • Active comparator
    Gait plus cognitive training

    Rehabilitation of walking/gait, combined with rehabilitation of cognitive function

    Behavioral: Gait training · Behavioral: cognitive training

  • Active comparator
    Gait plus arm training

    Rehabilitation of walking/gait, combined with rehabilitation of arm function

    Behavioral: Gait training · Behavioral: Arm training

Interventions

  • BehavioralGait training

    Treatment will include coordination exercises and over ground gait training for impaired muscle groups and related gait deficits. The therapy will be provided by a clinical physical therapist specializing in rehabilitation for stroke patients, according to established, conventional guidelines. The protocol was used in the investigators' prior studies, and is designed to restore voluntary control of ankle dorsiflexion during swing phase; hip flexion during swing phase, knee flexion at toe-off, knee flexion during swing phase; knee extension before heel strike; knee control during stance phase; pelvic control during stance phase; and whole body balance control during weight shifting. Newly-learned coordinated movements will be integrated into practice of coordinated gait components. Cognitive rehabilitation will begin with the least difficult aspects of attention control, and progress to the more difficult. Home practice and generalization exercises will be assigned.

  • Behavioralcognitive training

    Cognitive training is designed to enhance attention, intention, executive function, decision making and reaction time. Commercially available computer software will be used, as well as custom cognitive training.

  • BehavioralArm training

    Treatment will include coordination exercises for reaching and grasping. Activities will include movement of shoulder, elbow, wrist and fingers.

06

What researchers measure

Primary outcomes

  1. Change in the Gait Assessment and Intervention (G.A.I.T.) Score

    Coordination of walking, scored using the investigators' novel G.A.I.T. measure. This measure evaluated limb and joint movements while participants walk overground at preferred speed. Range of scale: 0 (normal) to 64 (extremely discoordinated gait).

    Time frame: pre-training (0 weeks), post training (about 12 weeks)

07

Results

Posted Feb 11, 2019
Limitations and caveats
Early closure leading to small numbers of subjects analyzed. early enrollment closure due to inability for the institution to hire skilled clinicians in a timely manner in order to enroll and treat participants in the available time frame.

Participant flow

Participant flow — Overall Study
MilestoneGait and Cognitive TrainingGait and Arm Training
Started57
Completed47
Not completed10
Withdrew: Withdrawal by subject10

Outcome measures

PrimaryChange in the Gait Assessment and Intervention (G.A.I.T.) Score

Coordination of walking, scored using the investigators' novel G.A.I.T. measure. This measure evaluated limb and joint movements while participants walk overground at preferred speed. Range of scale: 0 (normal) to 64 (extremely discoordinated gait).

Time frame:
pre-training (0 weeks), post training (about 12 weeks)
Reported as:
Mean · units on a scale
Change in the Gait Assessment and Intervention (G.A.I.T.) Score
units on a scaleGait and Cognitive TrainingGait and Arm Training
pre treatment mean28.8 ± 6.929.5 ± 3.8
post treatment mean29.9 ± 5.928.7 ± 7.7
Statistical analysis
  • Gait and Cognitive Training vs Gait and Arm Training · t-test, 2 sided · p = 0.54

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Gait and Cognitive Training0/4 (0%)0/4 (0%)1/4 (25%)
Gait and Arm Training0/7 (0%)0/7 (0%)0/7 (0%)
Most frequent other events
Most frequent other events
EventGait and Cognitive TrainingGait and Arm Training
back painMusculoskeletal and connective tissue disorders1/40/7

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Gait and Cognitive TrainingGait and Arm TrainingTotal
<=18 years000
Between 18 and 65 years459
>=65 years123
Sex: Female, Male
Sex: Female, Male(Participants)Gait and Cognitive TrainingGait and Arm TrainingTotal
Female336
Male246
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Gait and Cognitive TrainingGait and Arm TrainingTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American224
White358
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(Participants)Gait and Cognitive TrainingGait and Arm TrainingTotal
United States5712
08

Study locations

1 site
  • North Florida/South Georgia Veterans Health System, Gainesville, FL
    Gainesville, Florida 32608, United States
09

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 11, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02362282
Lead sponsor
VA Office of Research and Development
Responsible party
Sponsor
First posted
Feb 12, 2015
Start date
Dec 2013
Primary completion
Jun 2016
Completion
Jun 2016
Results posted
Feb 11, 2019
Last update
Feb 11, 2019

Study contacts

Janis J. Daly, PhD MS
principal investigator · North Florida/South Georgia Veterans Health System, Gainesville, FL

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion